Beijing Leadman Biochemistry Secures IVDR CE Certification for Two Biochemical Reagent Products

Stock News05-21

Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ) has announced that two of its biochemical reagent products have recently obtained IVDR CE certification issued by the EU notified body TÜV SÜD. The certified Carbon Dioxide (CO2) Assay Kit (PEP-C method) is primarily used to assess the body's acid-base balance and aid in the diagnosis of respiratory and metabolic acid-base disorders. The Leucine Aminopeptidase (LAP) Assay Kit (L-leucine-p-nitroanilide substrate method) is a commonly used clinical test for liver function, mainly assisting in the diagnosis of hepatobiliary system diseases and reflecting conditions such as hepatocyte injury and biliary obstruction. According to the EU In Vitro Diagnostic Medical Devices Regulation, the products with IVDR CE certification have met the essential requirements for entry into the EU market. This development is expected to enhance the company's overall competitiveness in overseas markets and will positively impact its international expansion and future business operations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1166469701?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-21 17:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1166469701","market":"other","top_or_hot":-1,"title":"Beijing Leadman Biochemistry Secures IVDR CE Certification for Two Biochemical Reagent Products","media":"Stock News","content":"<p>Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ) has announced that two of its biochemical reagent products have recently obtained IVDR CE certification issued by the EU notified body TÜV SÜD. The certified Carbon Dioxide (CO2) Assay Kit (PEP-C method) is primarily used to assess the body's acid-base balance and aid in the diagnosis of respiratory and metabolic acid-base disorders. The Leucine Aminopeptidase (LAP) Assay Kit (L-leucine-p-nitroanilide substrate method) is a commonly used clinical test for liver function, mainly assisting in the diagnosis of hepatobiliary system diseases and reflecting conditions such as hepatocyte injury and biliary obstruction. According to the EU In Vitro Diagnostic Medical Devices Regulation, the products with IVDR CE certification have met the essential requirements for entry into the EU market. This development is expected to enhance the company's overall competitiveness in overseas markets and will positively impact its international expansion and future business operations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beijing Leadman Biochemistry Secures IVDR CE Certification for Two Biochemical Reagent Products</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeijing Leadman Biochemistry Secures IVDR CE Certification for Two Biochemical Reagent Products\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-21 17:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ) has announced that two of its biochemical reagent products have recently obtained IVDR CE certification issued by the EU notified body TÜV SÜD. The certified Carbon Dioxide (CO2) Assay Kit (PEP-C method) is primarily used to assess the body's acid-base balance and aid in the diagnosis of respiratory and metabolic acid-base disorders. The Leucine Aminopeptidase (LAP) Assay Kit (L-leucine-p-nitroanilide substrate method) is a commonly used clinical test for liver function, mainly assisting in the diagnosis of hepatobiliary system diseases and reflecting conditions such as hepatocyte injury and biliary obstruction. According to the EU In Vitro Diagnostic Medical Devices Regulation, the products with IVDR CE certification have met the essential requirements for entry into the EU market. This development is expected to enhance the company's overall competitiveness in overseas markets and will positively impact its international expansion and future business operations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"","article_id":"1166469701","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1166469701","pubTimestamp":1779354744,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ) has announced that two of its biochemical reagent products have recently obtained IVDR CE certification issued by the EU notified body TÜV SÜD. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300289":"利德曼","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4109":"特种化学制品","CE":"塞拉尼斯","BK0046":"生物疫苗","BK0028":"国家队","BK0239":"医药制造"},"translate_title":"北京利德曼生化两款生化试剂产品获IVDR CE认证","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300289":1,"CE":1},"content_text":"Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ) has announced that two of its biochemical reagent products have recently obtained IVDR CE certification issued by the EU notified body TÜV SÜD. The certified Carbon Dioxide (CO2) Assay Kit (PEP-C method) is primarily used to assess the body's acid-base balance and aid in the diagnosis of respiratory and metabolic acid-base disorders. The Leucine Aminopeptidase (LAP) Assay Kit (L-leucine-p-nitroanilide substrate method) is a commonly used clinical test for liver function, mainly assisting in the diagnosis of hepatobiliary system diseases and reflecting conditions such as hepatocyte injury and biliary obstruction. According to the EU In Vitro Diagnostic Medical Devices Regulation, the products with IVDR CE certification have met the essential requirements for entry into the EU market. This development is expected to enhance the company's overall competitiveness in overseas markets and will positively impact its international expansion and future business operations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1166469701","isCrawlerRequest":true}